ArticleCureus2025
Impact of Lymph Node Involvement on Prognosis and Survival in Patients With Ovarian Carcinoma: A Clinicopathological Correlation Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparison of [Abdominal radiology (New York) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOvarian carcinoma remains a leading cause of gynecologic cancer mortality worldwide, primarily due to its late presentation and high recurrence rates.
objectiveThis study aims to determine the impact of lymph node involvement on prognosis and survival in patients with epithelial ovarian carcinoma and to correlate nodal status with clinicopathological parameters.
methodsThis retrospective cross-sectional study was conducted at Shalamar Medical and Dental College, Lahore, from September 2024 to May 2025. A total of 125 patients with histologically confirmed epithelial ovarian carcinoma who underwent primary cytoreductive surgery with lymphadenectomy were included. Data regarding patient demographics, tumor grade, FIGO stage, histologic subtype, and lymph node status were collected.
resultsLymph node metastasis was identified in 48 patients (38.4%). Node positivity showed a significant association with high-grade tumors (p = 0.02) and advanced FIGO stage (p < 0.001). The mean number of lymph nodes dissected was 14.2 ± 6.8, while the mean lymph node ratio was 0.21 ± 0.14. Patients with lymph node involvement demonstrated a markedly lower three-year overall survival rate of 42.7%, compared with 78.1% in node-negative cases (p = 0.003, log-rank test). On multivariate Cox regression, lymph node positivity (heart rate (HR) = 2.41, 95% confidence interval (CI): 1.38-4.21, p = 0.002) and advanced FIGO stage (HR = 3.05, 95% CI: 1.76-5.18, p < 0.001) emerged as independent predictors of poor survival. Conclusion: It is concluded that lymph node involvement is a significant independent prognostic factor in epithelial ovarian carcinoma, strongly associated with advanced stage, high tumor grade, and reduced survival. Accurate lymph node assessment should be routinely incorporated into surgical and pathological evaluation for precise staging and individualized management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.